PMID- 30260258 OWN - NLM STAT- MEDLINE DCOM- 20191030 LR - 20200309 IS - 1461-7285 (Electronic) IS - 0269-8811 (Print) IS - 0269-8811 (Linking) VI - 32 IP - 10 DP - 2018 Oct TI - Anhedonia and depression severity dissociated by dmPFC resting-state functional connectivity in adolescents. PG - 1067-1074 LID - 10.1177/0269881118799935 [doi] AB - INTRODUCTION: Given the heterogeneity within depression, in this study we aim to examine how resting-state functional connectivity (RSFC) in adolescents is related to anhedonia and depression severity on a continuum in line with the research domain criteria (RDoC) approach. METHODS: We examined how RSFC in the dorsal medial prefrontal cortex (dmPFC), nucleus accumbens (NAcc) and pregenual anterior cingulate cortex (pgACC) was related to anhedonia and depression severity in 86 adolescents (13-21 years). RESULTS: We found both anhedonia and depression severity related to decreased dmPFC RSFC with the precuneus, a part of the default mode network. However we also found that increased dmPFC connectivity with the ACC/paracingulate gyrus related to anhedonia whereas increased RSFC with the frontal pole related to depression severity. DISCUSSION: This work extends the view that the dmPFC is a potential therapeutic target for depression in two ways: 1. We report dmPFC connectivity in adolescents; and 2. We show different dmPFC RSFC specific to anhedonia and depression severity, providing neural targets for intervention in young people at risk of depression. FAU - Rzepa, Ewelina AU - Rzepa E AD - School of Psychology and Clinical Language Sciences, University of Reading, UK. FAU - McCabe, Ciara AU - McCabe C AUID- ORCID: 0000-0001-8704-3473 AD - School of Psychology and Clinical Language Sciences, University of Reading, UK. LA - eng GR - MRC_/Medical Research Council/United Kingdom PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20180927 PL - United States TA - J Psychopharmacol JT - Journal of psychopharmacology (Oxford, England) JID - 8907828 SB - IM MH - Adolescent MH - Anhedonia/*physiology MH - Brain/*diagnostic imaging MH - *Brain Mapping MH - Depressive Disorder, Major/diagnostic imaging/*physiopathology MH - Female MH - Gyrus Cinguli/diagnostic imaging MH - Humans MH - Magnetic Resonance Imaging MH - Male MH - Neural Pathways/diagnostic imaging MH - Nucleus Accumbens/diagnostic imaging MH - Prefrontal Cortex/diagnostic imaging MH - Severity of Illness Index MH - Young Adult PMC - PMC6380625 OTO - NOTNLM OT - DMN OT - Depression OT - adolescent OT - biomarker OT - dmPFC OT - resting-state COIS- Declaration of conflicting interest: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article EDAT- 2018/09/28 06:00 MHDA- 2019/10/31 06:00 PMCR- 2019/02/19 CRDT- 2018/09/28 06:00 PHST- 2018/09/28 06:00 [pubmed] PHST- 2019/10/31 06:00 [medline] PHST- 2018/09/28 06:00 [entrez] PHST- 2019/02/19 00:00 [pmc-release] AID - 10.1177_0269881118799935 [pii] AID - 10.1177/0269881118799935 [doi] PST - ppublish SO - J Psychopharmacol. 2018 Oct;32(10):1067-1074. doi: 10.1177/0269881118799935. Epub 2018 Sep 27.